SynthesisExploration of targeted anti-tumor therapy2025

Elacestrant in hormone receptor-positive metastatic breast cancer: a post-hoc analysis.

Azza Sarfraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.